# MVB Financial Corp: financial statements, quarterly

MVBF · Nasdaq · CIK 1277902 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/mvbf.md) · [Financials](/companies/mvbf/financials.md) · [Filings](/companies/mvbf/filings.md) · [Insiders](/companies/mvbf/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/mvbf/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Interest expense | $m | [18.5](/filings/0001277902-23-000187.md) | [18.6 d](/filings/0001277902-24-000014.md) | [19.9](/filings/0001277902-24-000056.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [1.2](/filings/0001277902-24-000141.md) | [1.4 d](/filings/0001277902-26-000030.md) | [1.3](/filings/0001277902-25-000084.md) | [1.4](/filings/0001277902-25-000168.md) | [0.6](/filings/0001277902-25-000197.md) | [2.8 d](/filings/0001277902-26-000030.md) | [1.2](/filings/0001277902-26-000065.md) | [1.2](/filings/0001277902-26-000084.md) | [6.3](/filings/0001277902-25-000197.md) | [1.2 d](/filings/0001277902-26-000030.md) | [1.5](/filings/0001277902-26-000065.md) | [3.7](/filings/0001277902-26-000084.md) |
| Net income | $m | [3.9](/filings/0001277902-25-000043.md) | [7.9](/filings/0001277902-25-000043.md) | [4.5](/filings/0001277902-26-000030.md) | [4.1](/filings/0001277902-26-000030.md) | [2.1](/filings/0001277902-26-000030.md) | [9.4](/filings/0001277902-26-000030.md) | [3.6](/filings/0001277902-26-000030.md) | [2.0](/filings/0001277902-26-000030.md) | [17.1](/filings/0001277902-26-000030.md) | [4.2](/filings/0001277902-26-000030.md) | [5.2](/filings/0001277902-26-000084.md) | [12.3](/filings/0001277902-26-000084.md) |
| Diluted EPS | $ per share | [0.29](/filings/0001277902-25-000043.md) | [0.61](/filings/0001277902-25-000043.md) | [0.34](/filings/0001277902-26-000030.md) | [0.31](/filings/0001277902-26-000030.md) | [0.16](/filings/0001277902-26-000030.md) | [0.72](/filings/0001277902-26-000030.md) | [0.27](/filings/0001277902-26-000065.md) | [0.15](/filings/0001277902-26-000084.md) | [1.32](/filings/0001277902-26-000030.md) | [0.32](/filings/0001277902-26-000030.md) | [0.39](/filings/0001277902-26-000065.md) | [0.93](/filings/0001277902-26-000084.md) |
| Basic EPS | $ per share | [0.30](/filings/0001277902-25-000043.md) | [0.62](/filings/0001277902-25-000043.md) | [0.35](/filings/0001277902-26-000030.md) | [0.32](/filings/0001277902-26-000030.md) | [0.16](/filings/0001277902-26-000030.md) | [0.73](/filings/0001277902-26-000030.md) | [0.28](/filings/0001277902-26-000065.md) | [0.16](/filings/0001277902-26-000084.md) | [1.36](/filings/0001277902-26-000030.md) | [0.33](/filings/0001277902-26-000030.md) | [0.41](/filings/0001277902-26-000065.md) | [0.95](/filings/0001277902-26-000084.md) |

- Revenue: not reported
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss, us-gaap:ProfitLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [587](/filings/0001277902-23-000187.md) | [398](/filings/0001277902-25-000043.md) | [640](/filings/0001277902-24-000056.md) | [456](/filings/0001277902-24-000122.md) | [611](/filings/0001277902-24-000141.md) | [318](/filings/0001277902-26-000030.md) | [251](/filings/0001277902-25-000084.md) | [399](/filings/0001277902-25-000168.md) | [300](/filings/0001277902-25-000197.md) | [244](/filings/0001277902-26-000084.md) | [178](/filings/0001277902-26-000065.md) | [313](/filings/0001277902-26-000084.md) |
| Total assets | $m | [3,438](/filings/0001277902-23-000187.md) | [3,314](/filings/0001277902-25-000043.md) | [3,547](/filings/0001277902-24-000056.md) | [3,288](/filings/0001277902-24-000122.md) | [3,419](/filings/0001277902-24-000141.md) | [3,129](/filings/0001277902-26-000030.md) | [3,020](/filings/0001277902-25-000084.md) | [3,224](/filings/0001277902-25-000168.md) | [3,233](/filings/0001277902-25-000197.md) | [3,309](/filings/0001277902-26-000084.md) | [3,322](/filings/0001277902-26-000065.md) | [3,546](/filings/0001277902-26-000084.md) |
| Total liabilities | $m | [3,166](/filings/0001277902-23-000187.md) | [3,025](/filings/0001277902-25-000043.md) | [3,256](/filings/0001277902-24-000056.md) | [2,991](/filings/0001277902-24-000122.md) | [3,116](/filings/0001277902-24-000141.md) | [2,823](/filings/0001277902-26-000030.md) | [2,710](/filings/0001277902-25-000084.md) | [2,922](/filings/0001277902-25-000168.md) | [2,905](/filings/0001277902-25-000197.md) | [2,975](/filings/0001277902-26-000084.md) | [2,987](/filings/0001277902-26-000065.md) | [3,201](/filings/0001277902-26-000084.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [271](/filings/0001277902-23-000187.md) | [289](/filings/0001277902-25-000043.md) | [292](/filings/0001277902-24-000056.md) | [297](/filings/0001277902-24-000122.md) | [303](/filings/0001277902-24-000141.md) | [306](/filings/0001277902-26-000030.md) | [310](/filings/0001277902-25-000084.md) | [302](/filings/0001277902-25-000168.md) | [328](/filings/0001277902-25-000197.md) | [334](/filings/0001277902-26-000030.md) | [335](/filings/0001277902-26-000084.md) | [345](/filings/0001277902-26-000084.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquity, us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [10.1 d](/filings/0001277902-24-000141.md) | [17.5 d](/filings/0001277902-26-000030.md) | [(25.3)](/filings/0001277902-25-000084.md) | [26.9 d](/filings/0001277902-25-000168.md) | [8.6 d](/filings/0001277902-25-000197.md) | [(10.5) d](/filings/0001277902-26-000030.md) | [14.1](/filings/0001277902-26-000065.md) | [7.4 d](/filings/0001277902-26-000084.md) | [(2.6) d](/filings/0001277902-25-000197.md) | [(15.0) d](/filings/0001277902-26-000030.md) | [(23.3)](/filings/0001277902-26-000065.md) | [5.2 d](/filings/0001277902-26-000084.md) |
| Capital expenditure | $m | [0.2 d](/filings/0001277902-24-000141.md) | [0.5 d](/filings/0001277902-26-000030.md) | [0.9](/filings/0001277902-25-000084.md) | [0.3 d](/filings/0001277902-25-000168.md) | [0.3 d](/filings/0001277902-25-000197.md) | [0.1 d](/filings/0001277902-26-000030.md) | [0.3](/filings/0001277902-26-000065.md) | [0.2 d](/filings/0001277902-26-000084.md) | [1.0 d](/filings/0001277902-25-000197.md) | [0.5 d](/filings/0001277902-26-000030.md) | [0.1](/filings/0001277902-26-000065.md) | [0.3 d](/filings/0001277902-26-000084.md) |
| Dividends paid | $m | [2.2 d](/filings/0001277902-24-000141.md) | [2.2 d](/filings/0001277902-26-000030.md) | [2.1](/filings/0001277902-25-000084.md) | [(1.7) d](/filings/0001277902-25-000168.md) | [6.1 d](/filings/0001277902-25-000197.md) | [2.2 d](/filings/0001277902-26-000030.md) | [2.2](/filings/0001277902-26-000065.md) | [2.2 d](/filings/0001277902-26-000084.md) | [2.1 d](/filings/0001277902-25-000197.md) | [2.2 d](/filings/0001277902-26-000030.md) | [2.2](/filings/0001277902-26-000065.md) | [2.2 d](/filings/0001277902-26-000084.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | [0.0 d](/filings/0001277902-25-000197.md) | [0.0 d](/filings/0001277902-26-000030.md) | not reported | not reported | [3.6 d](/filings/0001277902-25-000197.md) | [0.1 d](/filings/0001277902-26-000030.md) | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [12.9](/filings/0001277902-23-000187.md) | [13.0](/filings/0001277902-24-000056.md) | [12.9](/filings/0001277902-24-000122.md) | [13.1](/filings/0001277902-24-000141.md) | [13.1](/filings/0001277902-25-000084.md) | [13.0](/filings/0001277902-25-000168.md) | [13.2](/filings/0001277902-25-000197.md) | [13.2](/filings/0001277902-26-000065.md) | [13.1](/filings/0001277902-26-000084.md) | [13.0](/filings/0001277902-25-000197.md) | [13.2](/filings/0001277902-26-000065.md) | [13.2](/filings/0001277902-26-000084.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 12,967,507 at 2026-08-04, from the cover of the [10-Q filed 2026-08-05](/filings/0001277902-26-000084.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:35 ET. No prices; not investment advice.